-The Hindu By 2040, 12.4% of patients in the country will have that variant, reports Lancet A month after the Health Ministry set itself the target of eliminating tuberculosis (TB) by 2025, a new study in the medical journal Lancet says that India’s TB crisis is likely to get worse. According to the latest issue of the journal, Multidrug Resistant-Tuberculosis (MDR-TB), a version of the disease where patients do not respond to first-line...
More »SEARCH RESULT
Total Matching Records found : 977
Sponsors banned: Docs asked to raise funds for conferences -Durgesh Nandan Jha & Rema Nagarajan
-The Times of India NEW DELHI: The Indian Medical Association (IMA) has asked its state and local units to raise funds from member doctors to organise conferences and functions instead of seeking sponsorship. According to IMA office-bearers, the decision was taken at a meeting on Wednesday in view of allegations about pharmaceutical companies and the device industry shaping the content and style of medical conferences. "If doctors want to meet at a...
More »Branded Drugs need to be phased out: Doctors' groups
-The Times of India NEW DELHI: Doctors and public health groups have come together to suggest that the government should phase out branded Drugs in a calibrated manner and ban differential pricing under different brands to promote generic drug prescriptions. This comes in the wake of PM Narendra Modi's announcement that the government was working on a legal framework to ensure that doctors mandatorily prescribed low cost generic medicines. Following the PM's...
More »Generic medicines in a digital age -Dinesh S Thakur & Prashant Reddy T
-The Hindu We need a legal mechanism to ensure that all generics are of the same standard as the innovator product The Prime Minister’s recent announcement on making it mandatory for doctors to prescribe only the generic name, and not brand name of a drug, has led to a flutter. If enacted, the move will make it illegal for Indian doctors to write out a prescription for the trademark of the drug,...
More »Centre cracks whip, no stent can be withdrawn, for now -Sushmi Dey
-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (NPPA), the government has directed companies to maintain production,...
More »
